1367th Black-Hearted Middleman

Latest website: At this moment, He Xiaojun finally understood that Xiao Feng came to talk to him today about the plot of Sports New City.

It turns out that the boss is going to do something big!

It seems that the section of Sports New City is really interesting.

It seems that I really underestimated Xiao Feng before, thinking that he was just taking the land to engage in commercial comprehensive development, and in the end he would return to the old road of traditional real estate.

Unexpectedly, the pattern of the boss was not what he could have expected.

He doesn't want to engage in real estate here, he relies entirely on his own strength to build an industrial park there.

Moreover, this industrial park is far more than just a famous incubator.

This is completely prepared for the expansion of the domestic medical field in the future.

At first, it mainly supported the upstream and downstream of their Ninth Laboratory, but later, it was for all participants in the medical field.

It doesn't matter where your company is, and it doesn't matter whether you are in medicine or medical equipment.

As long as you have a good idea and get the approval of the Ninth Laboratory Audit Committee, then you can get the investment of Quanye Fund.

And where does the Quanye Fund get its money from?

According to Xiao Feng's idea, in fact, more than 70% of the funds were raised from the society!

From this point of view, what Xiao Feng is doing is not a simple one. What he has to do is to guide social funds and enter the field of upgrading the medical industry as a guide!

We must know that the country has advocated social funds and private capital to enter the field of medical care, and the slogan has been shouted for many years.

Even in the financial field, many openings have been opened for medical companies, but why has our domestic medical industry not been able to develop for so many years.

In the final analysis, it is because of the wrong way of supporting funds and industries.

Capital is profit-seeking, and what they always think is to earn the fastest and most money with the fastest speed and the smallest risk.

In the medical industry,

It is a capital-intensive and wisdom-intensive industry that requires a long period of investment.

Therefore, in this regard, there is a natural contradiction between medical research and capital.

In addition, many domestic pharmaceutical companies have made little progress in the research and development of original research drugs for so many years.

On the contrary, there are many pharmaceutical companies with frequent scandals, which makes capital even more distrustful of R&D companies.

So although the above is an original research drug company that has long advocated private capital and entered the country.

However, the matching between the two parties has not been very successful. What we can see more is that the capital of all parties frequently invests in the stock market, attacking pharmaceutical companies, and entering and exiting.

However, they all took the short, flat and fast route, relying on various information gaps, making a fortune, and then quickly ran away.

In doing so, not only did they fail to help those pharmaceutical companies grow, but on the contrary, they made many pharmaceutical companies that were not bad at first half dead.

After all, the company's stock price frequently rides a roller coaster, which is bound to affect the confidence of other investors, and even enterprise insiders will have distrust of the company's future due to frequent fluctuations in stock price.

And the funds that can really be deposited to help the development of enterprises are even rarer.

In fact, everyone who is engaged in the financial industry knows that betting on original drug companies is actually a very profitable industry.

For example, if you look at Pfizer, they developed a small blue pill that year, which directly increased their stock price tenfold.

Just such a drug alone made those investors make a lot of money.

And because of the patent protection of the drug, after the release of the little blue pill, the drug was sold exclusively by them for 13 years in the market.

In the past thirteen years, they have been able to reap tens of billions of dollars from the world every year just by relying on this drug...

If you are an investor in Pfizer, as long as you hold their stocks, even if you don’t cash them out, you will make a lot of money just by eating dividends every year.

And more than ten years later, even if you wait until the patent protection period expires, you are selling Pfizer's stock.

But at this time, Pfizer's stock has more than doubled by more than ten times...

Such a good thing for making money at both ends really made the investment in Pfizer back then a big investment institution's mouth full of oil.

Regardless of the recent years, the stocks of Apple and Google have skyrocketed in the market, but in fact you let the institutions that hold Pfizer stocks change them.

I'm afraid not many people are willing to change it. After all, the return on Pfizer's stock is not low at all.

Therefore, these domestic capital players are not actually unwilling to invest in companies that actually engage in research and development. The problem is that it is really difficult to meet such companies in China!

After all, over the years, they have also dealt with those well-known large domestic pharmaceutical companies.

But after some dealings, they also discovered that if you expect these companies to truly succeed in R&D, then you don't know that you will have to wait until the Year of the Monkey.

So it's better to make some quick money in the stock market.

The only thing that makes them feel infinitely pity is the Ninth Laboratory. This company can be said to be one of the few pharmaceutical companies in China that has the real ability to develop original drugs.

And judging from the original drugs produced by others, this company's ability is no worse than Pfizer, Johnson & Johnson, GlaxoSmithKline, such old world-class pharmaceutical companies!

But the damn thing is, this company is not listed at all!

What's even more hateful is that the background of this company is still very strong and mysterious.

Even if they wanted to talk to someone, they couldn't.

Even if they don't go public, they have nothing to do with them, so they can only hate their teeth, and then stare blankly.

But this time the situation is different. The Ninth Laboratory is planning to start anew this time.

The project they got this time seems to be just a fund focused on industry.

But they are more professional than any other capital, especially in the field of pharmaceuticals and medical devices.

Through their hands, one successful company after another will be hatched.

Those capitals who were gnashing their teeth at the Ninth Laboratory can gain real benefits through them this time.

The Quanye Fund of the Ninth Laboratory actually serves as a channel.

Help those financial institutions that have money but have no suitable direction to find the most suitable investment direction.

Why do these financial institutions trust them? It is because of the golden name of their Ninth Laboratory and their super ability to cover the bottom line.

"At the very beginning? We must set up cover-up procedures for those financial institutions, so that they are willing to give us their money to invest."

"But once Quanye Fund's reputation is established, and we have successfully invested in several companies in a row, hehe, this back-and-forth procedure can be removed."

"At that time, they will come or not. Believe me, even if we don't give them any promises, those capitals will rush to squeeze out the money and give us the money to put in the Quanye Fund."

"At that time, it will not be a matter of us giving them the interest rate difference. Instead, we will charge them management fees for fund escrow and proxy investment."

Xiao Feng was discussing with He Xiaojun the future process of Quanye Fund with a smile on his face.

And He Xiaojun also nodded frequently, very approving of Xiao Feng's statement.

It's really not that the two of them are too crazy, but because of their confidence in the scientists in the review committee of the Ninth Laboratory.

The seven members of the review committee were all human cloning experts appointed by Xiao Feng.

These people may be dismissive of modern medical technology, but they will definitely not lose sight of the future development direction of science.

Which project has a future, what kind of technology, what kind of field in the future, go back to the breakthrough.

They are absolutely clear about the impact it will have on the future medical field of mankind.

So once a project is approved by them, it is basically a certainty, and it will definitely be a success.

At that time, such a project will not only receive financial support from the Ninth Laboratory, but also receive technical support from them.

Originally, these enterprises may take five or even ten years to produce results.

However, with the support of the Ninth Laboratory, these enterprises may take two to three years, or even a year, to produce results.

In doing so, the risk can be said to be extremely low.

Moreover, it completely avoided the big pits of those large pharmaceutical companies that have already been listed, relying entirely on supporting the latest industries to get on the road.

Such an industry can be said to have great potential, and once it grows explosively, any one of them may become a hot spot in the stock market.

As long as a few are made, Quanye Fund can become the vane of the domestic venture capital industry.

Maybe it can't compare with those giants like Hongshan and Gaoling Capital.

But in the field of pharmaceutical and medical device investment, they are definitely the No. 1.

As long as there are five successful cases, then they will be in this field in the future, in a word, it will be the golden rule.

At that time, countless people and companies will take the initiative to approach them, hoping to gain their support.

And all kinds of capital will flock to them and treat them as guests.

Even if they know that they are black-hearted middlemen who earn the price difference, they will unconditionally give the money in their hands obediently.

This is the basic rule of the operation of the capital circle. At that time, they can not only make money from the investment projects, but also make money from those capitals.

Moreover, those capitals will not complain at all, instead they will take the initiative to offer the funds with a smile, for fear that Quanye Fund will not take them to play.

"I suddenly talked about this today, and I feel a little confused in my mind. This is a big event, so there is no rush."

"How about calling Lao Guan and Teacher He Fangzhou tomorrow, and let's have a good talk together."

"Finally implement the details of the fund's operation."

He Xiaojun suddenly said to Xiao Feng, Xiao Feng smiled and nodded.

"I'm also thinking about it, and I'm thinking, if you have funds on hand, you might as well buy some shares."

"You have been with me for so many years..."